PepGen (PEPG) Other Accumulated Expenses (2021 - 2026)
PepGen (PEPG) reported Other Accumulated Expenses of $2.4 million for Q1 2026, down 78.75% on a YoY basis from $11.5 million in Q1 2025, and up 1105.94% sequentially from $202000.0 in Q4 2025.
PepGen (PEPG) Other Accumulated Expenses (2021 - 2026) Analysis & Trends
PepGen (PEPG) has 6 years of Other Accumulated Expenses data on file, last reported at $2.4 million in Q1 2026.
- For the quarter ending Q1 2026, Other Accumulated Expenses fell 78.75% year-over-year to $2.4 million; the trailing twelve-month figure through Mar 2026 stood at $2.4 million (down 78.75% YoY), and the FY2025 full-year result was $202000.0, down 97.07% from the prior year.
- Other Accumulated Expenses improved to $2.4 million in Q1 2026, from $202000.0 in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $11.5 million in Q1 2025 to a low of $202000.0 in Q4 2025.
- A 5-year average of $3.2 million and a median of $1.6 million in 2022 frame the typical range for Other Accumulated Expenses.
- Peak annual rise in Other Accumulated Expenses reached 1103.99% in 2025, while the deepest fall reached 97.07% in 2025.
- Tracing PEPG's Other Accumulated Expenses over 5 years: stood at $1.1 million in 2022, then declined by 18.54% to $918000.0 in 2023, then surged by 651.96% to $6.9 million in 2024, then plunged by 97.07% to $202000.0 in 2025, then surged by 1105.94% to $2.4 million in 2026.
- Business Quant data shows PEPG's Other Accumulated Expenses at $2.4 million in Q1 2026, $202000.0 in Q4 2025, and $476000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | PepGen | 145.09 Mn | 145.09 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.44 Mn |
| Dec 31, 2025 | 202,000.00 |
| Sep 30, 2025 | 476,000.00 |
| Jun 30, 2025 | 8.90 Mn |
| Mar 31, 2025 | 11.46 Mn |
| Dec 31, 2024 | 6.90 Mn |
| Sep 30, 2024 | 2.68 Mn |
| Jun 30, 2024 | 944,000.00 |
| Mar 31, 2024 | 952,000.00 |
| Dec 31, 2023 | 918,000.00 |
| Sep 30, 2023 | 10.27 Mn |
| Jun 30, 2023 | 1.14 Mn |
| Mar 31, 2023 | 1.87 Mn |
| Dec 31, 2022 | 1.13 Mn |
| Sep 30, 2022 | 918,000.00 |
| Jun 30, 2022 | 1.62 Mn |
| Mar 31, 2022 | 1.56 Mn |
| Dec 31, 2021 | 533,000.00 |